旭輝控股集團(00884.HK):獲接納購買的票據最終本金總額為7.82億元
格隆匯4月14日丨旭輝控股集團(00884.HK)發佈公吿,票據要約於2022年4月12日屆滿。在購買要約所載條款及條件的規限下,就於屆滿期限或之前有效提交的該等票據本金額中每人民幣10,000元應付的金額為人民幣10,000元。獲接納購買的該等票據最終本金總額為人民幣7.82億元,佔尚未贖回的該等票據本金總額合計約52.93%。
根據要約購回的該等票據已註銷。於本公吿日期,完成要約及獲接納票據註銷後,該等票據中的本金總額人民幣6.95億元尚未贖回。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.